Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126629371 | 12662937 | 1 | I | 20160718 | 20160818 | 20160818 | PER | US-STRIDES ARCOLAB LIMITED-2016SP010750 | STRIDES | GARLO K, DRESSEL D, SAVIC M, VELLA J.. SUCCESSFUL ECULIZUMAB TREATMENT OF RECURRENT POSTPARTUM ATYPICAL HEMOLYTIC UREMIC SYNDROME AFTER KIDNEY TRANSPLANTATION. CLIN-NEPHROL-CASE-STUD. 2015;2015(1):1-6 | 0.00 | Y | 0.00000 | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126629371 | 12662937 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | UNK | U | U | 90687 | |||||||||
| 126629371 | 12662937 | 2 | SS | PREDNISOLONE. | PREDNISOLONE | 1 | UNK (LOW DOSE) | U | U | 0 | |||||||||
| 126629371 | 12662937 | 3 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126629371 | 12662937 | 1 | Immunosuppression |
| 126629371 | 12662937 | 2 | Immunosuppression |
| 126629371 | 12662937 | 3 | Immunosuppression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126629371 | 12662937 | Exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |